У нас вы можете посмотреть бесплатно ImmunoLogic, Episode 8: "A One-Two Punch for Breast Cancer" With Julia C. Tchou, MD, PhD, FACS или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
We're excited to introduce another episode of the ImmunoLogic video podcast, hosted by Joseph Fraietta, PhD, an assistant professor of microbiology and the director of the Fraietta Lab at the University of Pennsylvania. Fraietta is joined by cohost Janna Minehart, MD, a clinical fellow in oncology (Master of Science Translational Research Program) at the University of Pennsylvania. Our hope is that this show will serve as a critical forum for clinicians, translational researchers, and biotechnology professionals to explore the evolving landscape of immunotherapy. We're seeking to bridge cutting-edge research with practical applications and delve into how immune-based therapies transition from innovative discoveries to transformative patient care solutions. In this episode, the cohosts speak with Julia C. Tchou, MD, PhD, the director of the Breast Surgery Research Program at Perelman School of Medicine at the University of Pennsylvania, about the potential of combining immunotherapy approaches and surgery in the treatment of breast cancer. Tchou, Fraietta, and Minehart cover topics including why breast cancer has been considered “immunologically cold” and early immunotherapy approaches, the design and results of a low-dose radiation + pembrolizumab window-of-opportunity study, using tumors as an in situ vaccine, and the future of personalized cancer vaccines and intratumoral vaccine and immune modulator strategies. ImmunoLogic is tailored for an audience fluent in the language of medicine and biotechnology, offering data-driven insights while maintaining accessibility. This podcast is an essential resource for those driving the future of immunotherapy.